Atlas Trials

Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia

Clinical trial NCT04571645 · TERMINATED

Trial details

NCT number
NCT04571645
Sponsor
Jazz Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2021-04-30
Primary completion
2022-05-16
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.